Clinical Trial Update: Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating nivolumab and ipilimumab with and without Camu Camu in metastatic renal cell carcinoma, including clear cell and sarcomatoid s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma
• Sarcomatoid Renal Cell Carcinoma

Drugs mentioned

• Camu Camu extract (camu camu extract)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING